serving models is very profitable (70%+) but the issue is you need to invest in training the next iteration. but so far all of anthropics models have been profitable fully loaded

the vast majority of the labs revenue is from enterprise api usage (theres public sources from the information and ramp). but the risk there is customer concentration, where most of the revenue comes from other tech companies and a chunk of it is from foreign labs distilling

so i am drawing a conclusion that the labs' business model is good, maybe not as great as boosters think it is. if they make real progress on the biosciences like drug discovery that could turn it into an amazing business